Literature DB >> 7510616

Over-the-counter histamine H2-receptor antagonists. How will they affect the treatment of acid-related diseases?

S Holt1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 7510616     DOI： 10.2165/00003495-199447010-00001

Source DB:  PubMed          Journal:  Drugs        ISSN： 0012-6667            Impact factor:   9.546


× No keyword cloud information.
  24 in total

1.  [Adverse effects of ulcer drugs before and after release of cimetidine, ranitidine and sucralfate for over-the-counter sale].

Authors:  M Andersen; J S Schou
Journal:  Ugeskr Laeger       Date:  1991-05-13

Review 2.  Acid suppression as treatment for NSAID-related peptic ulcers.

Authors:  C W Howden; S Holt
Journal:  Am J Gastroenterol       Date:  1991-12       Impact factor: 10.864

3.  Over the counter sales of histamine-2 receptor antagonists.

Authors:  H Petersen
Journal:  Scand J Gastroenterol Suppl       Date:  1988

4.  Safety implications of the over-the-counter availability of H2-antagonists.

Authors:  M Andersen; J S Schou
Journal:  Drug Saf       Date:  1993-03       Impact factor: 5.606

Review 5.  Omeprazole. Overview and opinion.

Authors:  S Holt; C W Howden
Journal:  Dig Dis Sci       Date:  1991-04       Impact factor: 3.199

6.  Conventional versus on-demand therapy for duodenal ulcer: results of a controlled therapeutic trial.

Authors:  V K Thorat; S P Misra; B S Anand
Journal:  Am J Gastroenterol       Date:  1990-03       Impact factor: 10.864

7.  Computer assessment of life-style in a gastroenterology clinic.

Authors:  S Holt; M Guram; M Smith; H A Skinner
Journal:  Dig Dis Sci       Date:  1992-07       Impact factor: 3.199

8.  The Lugano statements on controlled clinical trials.

Authors:  A L Blum; T C Chalmers; E Deutsch; J Koch-Weser; A Rosén; N Tygstrup; R Zentgraf
Journal:  J Int Med Res       Date:  1987 Jan-Feb       Impact factor: 1.671

9.  Changing pattern of gastric cancer in Oxfordshire.

Authors:  E Rios-Castellanos; F Sitas; N A Shepherd; D P Jewell
Journal:  Gut       Date:  1992-10       Impact factor: 23.059

10.  Early gastric cancer: 46 cases treated in one surgical department.

Authors:  H M Sue-Ling; I Martin; J Griffith; D C Ward; P Quirke; M F Dixon; A T Axon; M J McMahon; D Johnston
Journal:  Gut       Date:  1992-10       Impact factor: 23.059
View more
  8 in total

Review 1.  Treatment of gastro-oesophageal reflux disease in adults.

Authors:  J P Galmiche; E Letessier; C Scarpignato
Journal:  BMJ       Date:  1998-06-06

Review 2.  Ranitidine: a pharmacoeconomic evaluation of its use in acid-related disorders.

Authors:  J E Frampton; D McTavish
Journal:  Pharmacoeconomics       Date:  1994-07       Impact factor: 4.981

Review 3.  Formulary management of drugs for cancer-associated hypercalcaemia.

Authors:  S J Gallacher
Journal:  Pharmacoeconomics       Date:  1996-01       Impact factor: 4.981

4.  Switching the histamine H2 receptor antagonist famotidine to nonprescription status in Canada. An economic evaluation.

Authors:  R F Tasch; R Goeree; C J Henke; B J O'Brien
Journal:  Pharmacoeconomics       Date:  1996-01       Impact factor: 4.981

5.  Proton pump inhibitors: perspectives of patients and their GPs.

Authors:  J Grime; K Pollock; A Blenkinsopp
Journal:  Br J Gen Pract       Date:  2001-09       Impact factor: 5.386

6.  Habit, prejudice, power and politics: issues in the conversion of H2-receptor antagonists to over-the-counter use.

Authors:  R H Hunt
Journal:  CMAJ       Date:  1996-01-01       Impact factor: 8.262

7.  Are H2 receptor antagonists safe over the counter drugs?

Authors:  M Andersen; J S Schou
Journal:  BMJ       Date:  1994 Aug 20-27

Review 8.  A risk-benefit assessment of drugs used in the eradication of Helicobacter pylori infection.

Authors:  A Hackelsberger; P Malfertheiner
Journal:  Drug Saf       Date:  1996-07       Impact factor: 5.606
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.